Long-Term Follow-Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
07 05 2019
Historique:
entrez: 7 5 2019
pubmed: 7 5 2019
medline: 18 8 2020
Statut: ppublish

Résumé

Background The natural history and long-term outcome in pediatric patients with idiopathic ventricular fibrillation ( IVF ) are poorly characterized. We sought to define the clinical characteristics and long-term outcomes of a pediatric cohort with an initial diagnosis of IVF . Methods and Results Patients were included from an International Registry of IVF (consisting of 496 patients). Inclusion criteria were: (1) VF with no identifiable cause following comprehensive analysis for ischemic, electrical or structural heart disease and (2) age ≤16 years. These included 54 pediatric IVF cases (age 12.7±3.7 years, 59% male) among whom 28 (52%) had a previous history of syncope (median 2 syncopal episodes [interquartile range 1]). Thirty-six (67%) had VF in situations associated with high adrenergic tone. During a median 109±12 months of follow-up, 31 patients (57%) had recurrence of ventricular arrhythmias, mainly VF . Two patients developed phenotypic expression of an inherited arrhythmia syndrome during follow-up (hypertrophic cardiomyopathy and long QT syndrome, respectively). A total of 15 patients had positive genetic testing for inherited arrhythmia syndromes. Ten patients (18%) experienced device-related complications. Three patients (6%) died, 2 due to VF storm. Conclusions In pediatric patients with IVF , a minority develop a definite clinical phenotype during long-term follow-up. Recurrent VF is common in this patient group.

Identifiants

pubmed: 31057083
doi: 10.1161/JAHA.118.011172
pmc: PMC6512137
doi:

Substances chimiques

MYH7 protein, human 0
NAV1.5 Voltage-Gated Sodium Channel 0
Ryanodine Receptor Calcium Release Channel 0
SCN5A protein, human 0
Cardiac Myosins EC 3.6.1.-
Myosin Heavy Chains EC 3.6.4.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e011172

Références

J Am Coll Cardiol. 2015 Jul 28;66(4):470-7
pubmed: 26205599
Circ Cardiovasc Genet. 2017 Jun;10(3):
pubmed: 28600387
Heart Rhythm. 2013 Dec;10(12):1932-63
pubmed: 24011539
JAMA. 1982 Mar 12;247(10):1485-90
pubmed: 7035698
N Engl J Med. 2008 May 8;358(19):2016-23
pubmed: 18463377
Eur Heart J. 2015 Nov 1;36(41):2793-2867
pubmed: 26320108
J Am Heart Assoc. 2019 May 7;8(9):e011172
pubmed: 31057083
Circ Genom Precis Med. 2018 Feb;11(2):e001424
pubmed: 29453246
Circ Arrhythm Electrophysiol. 2011 Aug;4(4):441-7
pubmed: 21593198
Circ Arrhythm Electrophysiol. 2016 Oct;9(10):
pubmed: 27733492
J Am Coll Cardiol. 2017 May 2;69(17):2134-2145
pubmed: 28449774
J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615
pubmed: 25908064

Auteurs

Antonio Frontera (A)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.
2 Liryc Institute Bordeaux France.

Konstantinos Vlachos (K)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Takeshi Kitamura (T)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Saagar Mahida (S)

3 Department of Cardiac Electrophysiology and Inherited Cardiac Diseases Liverpool Heart and Chest Hospital Liverpool United Kingdom.

Xavier Pillois (X)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.
2 Liryc Institute Bordeaux France.

Gerard Fahy (G)

4 Cork University Hospital Cork Ireland.

Christelle Marquie (C)

5 Univ. Lille CHU Lille, F-59000 Lille France.

Riccardo Cappato (R)

6 Humanitas Clinical and Research Center Rozzano, Milan, Italy and Humanitas University, Department of Biomedical Sciences Milan Italy.

Graham Stuart (G)

7 Bristol Heart Institute Bristol United Kingdom.

Pascal Defaye (P)

8 Centre Hospitalier University of Grenoble France.

Juan Pablo Kaski (JP)

9 Centre for Inherited Cardiovascular Diseases Great Ormond Street Hospital London United Kingdom.
10 UCL Institute of Cardiovascular Science London United Kingdom.

Joris Ector (J)

11 University Hospital Gasthuisberg Leuven Belgium.

Alice Maltret (A)

12 Hôpital Necker Enfants Malades Service de Cardiologie Pédiatrique et Centre de Référence des Maladies Cardiaques Héréditaires Université Paris Descartes Paris France.

Patrice Scanu (P)

13 Centre Hospitalier University of Caen France.

Jean-Luc Pasquie (JL)

14 Centre Hospitalier University of Montpellier France.

Isabelle Deisenhofer (I)

15 Herzzentrum München Munich Germany.

Ivan Blankoff (I)

16 Centre Hospitalier University of Charleroi Belgium.

Daniel Scherr (D)

17 Division of Cardiology Department of Medicine Medical University of Graz Austria.

Martin Manninger (M)

17 Division of Cardiology Department of Medicine Medical University of Graz Austria.

Yoshifusa Aizawa (Y)

18 Niigata University Graduate School of Medical and Dental Science Niigata Japan.

Linda Koutbi (L)

19 Hôpital La Timone Marseille France.

Arnaud Denis (A)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Thomas Pambrun (T)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Philippe Ritter (P)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Frederic Sacher (F)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Meleze Hocini (M)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.
2 Liryc Institute Bordeaux France.

Philippe Maury (P)

20 Centre Hospitalier University of Toulouse France.

Pierre Jaïs (P)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.
2 Liryc Institute Bordeaux France.

Pierre Bordachar (P)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.
2 Liryc Institute Bordeaux France.

Michel Haïssaguerre (M)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.
2 Liryc Institute Bordeaux France.

Nicolas Derval (N)

1 Electrophysiology Department, Hopital Haut Lévêque Bordeaux France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH